“German officials will discuss a reported U.S. attempt to secure the rights to any coronavirus vaccine developed by a German pharmaceutical company in crisis meetings on Monday, amid concerns that the Trump administration was trying to monopolize the market,” the Washington Post reports.
“Interior Minister Horst Seehofer, when asked to confirm a report the Trump administration was attempting to secure exclusive rights to any vaccine created by the German biopharmaceutical firm CureVac, said he had ‘heard from several other members of government today that is the case.'”
“Top White House aides were unaware of any communication by or offer from President Trump to CureVac… The official cautioned, however, that Trump often has private conversations of which his staff is not aware, and therefore the official could not definitively rule out that any such discussion had occurred.”


?Political Trivia
Eight moments in political history. Put them on a timeline.
Play →
Five senators. Three bills. Can you guess how they all voted?
Play →
Nine Justices. One case. How did they rule?
Play →
Do you have your finger on the pulse of America?
Play →
Four questions a day.
Play →
A new game every day.